The Role Of Genomics In Future Of Medicine – The Personalis View

Personalis CEO John West, the former head of Solexa, talks about the clinical expansion plans he has for a company that currently already accounts for 4% of the global DNA and RNA sequencing.

The Biochemist Artist

Among the few upsides of COVID-19 has been the light shone on DNA sequencing. Sequencing and sharing the information on the novel coronavirus in January 2020 was the first vital step in understanding and then controlling the virus.

As new variants of the virus emerged late in the year, the value of next generation sequencing as a health...

More from Innovation

More from In Vivo